A Single Dose of Neuropeptide S in the Amygdala Completely Blocked PTSD-like Behavior in Rats — and It Works Through the NPY System

Rats were exposed to predator-scent stress (PSS) as a PTSD model, then received microinjections of NPS into the basolateral amygdala 1 hour post-exposure. Behavioral testing assessed anxiety responses long-term. Molecular analyses measured hippocampal expression of NPY, NPY-Y1R, and BDNF. Receptor antagonist experiments (NPS-RA and NPY-Y1RA, alone and combined) dissected the mechanism. Circulating corticosterone was measured at multiple time points.

PTSD affects millions of people and current treatments often fall short. This study identifies neuropeptide S as a potential early-intervention target — a single dose given shortly after trauma could prevent PTSD from developing. The unexpected discovery that NPS works through the NPY system creates a mechanistic bridge between two major anxiety-regulating peptide pathways, potentially opening dual-target therapeutic strategies.

This study connects two major neuropeptide systems — NPS and NPY — in the context of trauma response, a connection not previously appreciated. It supports the growing concept that the brain's peptide systems don't work in isolation but form interconnected networks that regulate stress resilience. The finding that a brief, early intervention can prevent long-term behavioral pathology aligns with the clinical goal of developing 'golden hour' treatments for PTSD.

The study was conducted in male rats using a predator-scent stress model, which may not fully capture human PTSD. Direct brain microinjection is not a feasible delivery method in humans. The long-term durability of the protective effect was not fully characterized. Female rats were not included, despite known sex differences in PTSD prevalence and neuropeptide biology.